Ascent Industries (ACNT) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
31 Mar, 2026Company overview and business model
Operates as a specialty chemicals platform, developing and supplying performance-driven chemical solutions for diverse end markets including energy, household, industrial, personal care, coatings, adhesives, agriculture, water treatment, construction, automotive, and more.
Product portfolio includes surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates in both petroleum-based and bio-based formulations.
Provides custom manufacturing services, including product development, process optimization, scale-up, and commercial production, leveraging both dedicated and flexible multi-purpose manufacturing systems.
Incorporated in 1958, with roots dating back to 1945, and operates three production facilities in Tennessee, South Carolina, and Virginia.
Common stock is listed on the Nasdaq Global Market under the symbol "ACNT."
Financial performance and metrics
As of March 27, 2026, there were 9,243,948 shares of common stock issued and outstanding.
The company has 24,000,000 shares of authorized capital stock, all common stock with a par value of $1.00 per share.
Use of proceeds and capital allocation
Net proceeds from securities sales are expected to be used for general corporate purposes, including capital expenditures, debt reduction or refinancing, recapitalization, acquisitions, and additions to working capital.
The specific application of proceeds for each tranche will be detailed in the applicable prospectus supplement.
Latest events from Ascent Industries
- Gross margin surged and net loss narrowed, with double-digit revenue growth targeted for 2026.ACNT
Q4 20253 Mar 2026 - Strategic transformation and operational gains drive strong profit growth and future upside.ACNT
IAccess Alpha Virtual MicroCap Conference3 Mar 2026 - Gross profit and adjusted EBITDA surged despite lower sales, driven by cost and efficiency gains.ACNT
Q3 202413 Feb 2026 - Transformed specialty chemical firm targets $500M revenue by 2030 through organic growth and M&A.ACNT
16th Annual Midwest Ideas Conference3 Feb 2026 - Q2 2024 profitability rebounded on cost actions, with strong margins and liquidity.ACNT
Q2 20242 Feb 2026 - Strong margin expansion, cash generation, and debt-free status set stage for 2025 growth.ACNT
Q4 202417 Dec 2025 - Transformed into a focused specialty chemicals firm, driving margin growth and preparing for expansion.ACNT
The Gateway Conference 202516 Dec 2025 - Shareholders will vote virtually in June 2025 on directors, pay, and auditor ratification.ACNT
Proxy Filing2 Dec 2025 - Shareholders to ratify Baker Tilly as auditor after Moss Adams merger, Board recommends approval.ACNT
Proxy Filing2 Dec 2025